GLP-1 Medications for Addiction & Reward: A Breakthrough in Mental Health Treatment in Reno, NevadaIntroduction: Why GLP-1 Is Being Talked About Beyond Weight Loss

Glucagon-like peptide-1 (GLP-1) receptor agonists—like semaglutide and liraglutide—are widely known for treating type 2 diabetes and obesity.

But emerging research is shifting the conversation. These medications may also modulate reward pathways in the brain, offering a novel, biologically grounded approach to addiction, compulsive behaviors, and psychiatric symptoms.

For patients in Reno, Nevada, this represents a potential paradigm shift in how we approach treatment-resistant patterns like binge eating, alcohol use, and even certain behavioral addictions.